Medication safety

MediSafe organizes your clinical base, cross-checks alerts and shows a visual traffic light before a problem catches you off guard.

Before issuing its result, MediSafe can integrate the medical information already stored in LifeQR and expand it with medical history, studies, lab work, imaging and clinical notes. It then contrasts medication and clinical context against clinical engines, official regulatory databases and pharmacovigilance sources to generate a clearer, portable and multilingual output.

Your LifeQR code stays exactly the same Informational report ready to share with your physician Clear outcome by level: red, yellow or green

Especially useful for tourists, workers in transit, older adults while traveling or children: the medical base can be prepared in the language of the country where the user is located, whether medication was entered by brand name or active ingredient.

Global impact

US$42 billion per year: estimated global cost associated with medication errors.

Emergency care

More than 1.5 million emergency visits per year and almost 500,000 hospitalizations from adverse drug events in the U.S.

Medication reconciliation

More than 40% of medication errors are linked to poor reconciliation at admission, transfer and discharge; close to 20% of those errors cause harm.

How it works

What MediSafe does

MediSafe contrasts the medication already stored in the LifeQR profile with clinical engines, official regulatory databases and pharmacovigilance sources before issuing its traffic-light result. It can also organize medical history, studies, lab work, imaging and reports, and review every drug by brand name or active ingredient to support clearer clinical reading in any country.

Important note

This is an informational and clinical collaboration tool. In its medication safety materials, the WHO indicates that patient tools should be used in collaboration with healthcare professionals.

Why it is useful

Why it is useful

Medication errors and incomplete treatment information remain a major cause of preventable harm. That is why a tool that gathers medication, allergies, history, studies, lab work and imaging in a portable format can help reduce exposure to avoidable admissions, duplicated work and delays when the person is far from their usual health system or facing a language change.

Mobility and response

Travel, transfers and environments where every minute matters

For tourists, workers in transit, older adults while traveling, children and field teams, the value becomes even clearer: when someone is far from their usual system, faces a language change or needs a faster response, carrying medication, studies, history and alerts in a multilingual base helps preserve continuity of care.

Validation layers

How MediSafe validates before issuing the traffic light

Whenever a new drug is added or the medical history changes, MediSafe runs an exhaustive review of the profile. It does not stop at a brand name: it normalizes medication, recognizes active ingredients and equivalents, reevaluates background, studies, lab work and imaging, contrasts the combination with specialized clinical engines, verifies current regulatory labeling and prepares the base to be shown in the local language where it is needed.

Normalization and interoperability

  • RxNorm: normalizes clinical names and links vocabularies used by pharmacy and interaction software, including First Databank, Micromedex, Multum and Gold Standard.
  • MED-RT: reference pharmacologic terminology and successor to NDF-RT for drug classifications and clinical relationships.
  • RxClass: connects pharmacologic classes with RxNorm members and lets you navigate classes sourced from ATC, MED-RT, FDA/SPL and others.
  • ATC: can be used as an additional layer to group therapeutic families and evaluate class-level duplication or conflicts.

Clinical interaction and screening engines

  • FDB MedKnowledge: licensed engine for clinically significant interactions; includes prescription drugs, OTC products, alternative therapies and even inactive ingredients.
  • Medi-Span Clinical Screening: screening for drug-drug, drug-food and drug-alcohol interactions, with severity, documentation, management, onset and clinical context such as age, pregnancy or lactation.
  • DrugBank: provides drug-drug, drug-category and category-category interactions with structured severity.
  • Micromedex: evidence-based clinical reference with interactions, IV compatibility, identification and drug comparison, updated daily.
  • UpToDate Lexidrug / Facts & Comparisons: reviews drug-drug interactions, allergies, pregnancy, lactation, diseases, foods, alcohol and therapeutic duplication with risk scales.
  • Oracle Health Multum: pharmacologic reference used by Oracle Health EHR for drug descriptions, interactions and utilization review support.
  • BNF Interactions: lets you search interactions and shows severity and evidence type.
  • Gold Standard Drug Database / Clinical Pharmacology: integrable drug information solutions for medication decision support.

Regulatory sources and official labeling

  • DailyMed: NLM database with the latest labeling submitted to the FDA and currently in use.
  • openFDA Drug Label API: public SPL label API for prescription and OTC drugs.
  • Drugs@FDA: includes most products approved since 1939 and states that it updates daily.
  • FDA NDC Directory: NDC code directory with daily updates for products listed with the FDA.
  • GSRS / UNII: unique ingredient identifiers generated by FDA and used in electronic listings such as DailyMed.
  • EMA ePI: authorized electronic product information in the European Union, focused on accessibility, searchability and multilingual capacity.
  • emc (UK): updated, approved and regulated information for medicines authorized in the United Kingdom.
  • CIMA (AEMPS, Spain): official information updated daily for medicines authorized in Spain.
  • Health Canada Drug Product Database: authorized medicines database for Canada, with nightly updates and access to product monographs.
  • TGA Product Information / ARTG: TGA-approved information on quality, safety and efficacy, plus the public register of therapeutic goods legally supplied in Australia.
  • ANMAT National Medicines Formulary: official free-access database with medicines registered and marketed in Argentina.

Special layers

  • MedlinePlus Herbs and Supplements: adds effectiveness, usual dose and interaction information for herbs and supplements.
  • LactMed: peer-reviewed database on drugs and other substances during breastfeeding, with milk levels, potential effects and therapeutic alternatives.

Pharmacovigilance and safety signals

  • FAERS / openFDA: repository of adverse events and medication errors submitted to the FDA; useful as a post-marketing signal, although the FDA clarifies that it does not prove causality or allow incidence calculation.
  • EudraVigilance: EMA system for managing and analyzing suspected adverse reactions in the EEA.
  • VigiBase: global database of adverse event reports for medicines and vaccines under the WHO monitoring program, administered by UMC.
Extra protection layer

LifeQR can add automatic alerts and exact GPS location during an emergency

Beyond MediSafe's clinical and multilingual analysis, LifeQR can automatically notify emergency contacts and share the exact GPS location where the event happened. This adds an extra protection layer when the person cannot explain their situation by themselves.

Useful for tourists, cruise travelers, workers in transit, older adults on the move and children.
Reduces friction when the emergency happens far from home or in another language.
Adds visibility for family, caregivers and response teams without breaking the unified LifeQR experience.
Visual reading

MediSafe traffic light

Red
Yellow
Green

Green

Green: with the available information and the sources consulted at the time of analysis, no relevant alerts were detected for the combination entered.

Yellow

Yellow: a possible interaction, duplication, precaution or conflict was detected and should be reviewed before moving forward.

Red

Red: a possible major interaction, contraindication or high-risk warning was detected and deserves priority review with a physician or pharmacist.

The visual traffic light logic is consistent with risk and severity modules used by tools such as Facts & Comparisons, DrugBank and BNF.

Sources and reference frameworks

Data sources and reference frameworks

WHO, CDC, NLM/NIH, FDA, EMA, AEMPS, Health Canada, TGA, ANMAT, UMC/WHO Programme for International Drug Monitoring, in addition to clinical and regulatory engines such as RxNorm, MED-RT, RxClass, FDB MedKnowledge, Medi-Span, DrugBank, Micromedex, UpToDate Lexidrug, Facts & Comparisons, Oracle Health Multum, BNF, Gold Standard Drug Database, Clinical Pharmacology, DailyMed, openFDA, Drugs@FDA, NDC Directory, GSRS/UNII, EMA ePI, emc, CIMA, Canada's Drug Product Database, TGA Product Information, ANMAT's national formulary, MedlinePlus Herbs & Supplements, LactMed, FAERS, EudraVigilance and VigiBase.

MediSafe

Activate MediSafe for this record

MediSafe adds a clinical layer for medication, medical history, studies, lab work and imaging, with a clearer output designed for multilingual and mobility contexts.

Your LifeQR code stays exactly the same Informational report ready to share with your physician Clear outcome by level: red, yellow or green